Public Health
CRISPR uncovers possible antidote for death cap mushroom poisoning
Researchers have figured out how the mushroom's main toxin enters human cells — and maybe how to stop it.
New drug candidates found in an unlikely place
Costa Rica’s famed sloths harbor bacteria in their fur which can create antibiotic compounds — a potential source of future therapies.
LSD effective as major depression therapy in phase 2 trial
MindMed and University Hospital Basel have announced top line results for their phase 2 trial.
Nurses are breaking the mold to set out on their own
Tech platform Hydreight wants to help nurses go into business for themselves by being a turnkey solution.
DMT appears effective for depression up to six months later
Small Pharma has announced the results of a six-month follow-up for their phase 2a trial of DMT for depression.
“Sunshine Calls” help depression and loneliness, study finds
A trial of “Sunshine Calls” found that the empathy-based phone calls helped reduce depression symptoms in older patients.
One way to speed up clinical trials: Skip right to the data with electronic medical records
It takes around 17 years for medical research to translate into clinical practice — why not use EMR data to speed things up?
Epilepsy surgery has a success rate of only 50%. This digital brain may change that.
Using patient data and AI, French researchers have created a digital model of the brain to figure out which brain region needs removed.
Viruses cause 200+ diseases. This one drug may be able to treat them all.
New Zealand-based startup Kimer Med wants to create an antiviral that would be effective against many known viruses — and unknown.
Narcan is now available over-the-counter in the US
Naloxone administered by nasal spray can be a lifesaving drug with minimal side effects. It's now approved for over-the-counter use in the U.S.